Davis Jennifer L.'s Form 4 filing
Procter & Gamble Co (PG) · filed Apr 30, 2025
- Accession no.
- 0001127602-25-012786
- Filed
- Apr 30, 2025
- Trade date
- Feb 18-Apr 29, 2025
- Filing delay
- 71 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market sales total $161.4K. It was filed 71 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Jennifer L.CIK 0001916665 | Officer (CEO - Health Care) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | Common Stock | SSaleDisposed | −1,000 | $161.38F1 | −$161,380 | 51,964.92 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Common Stock | AGrant or awardAcquired | +22.16 | $0.00 | $0 | 179.89 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Weighted average price of the shares sold. The price range was $161.38 to $161.40. Full information regarding the number of shares sold at each separate price available upon request.
Referenced by the price of 1 transaction in Table I.